LEETRO
430425
Geovis Insighter Technology
920116
Beijing Global Safety Technology
300523
4
Zhejiang JW Precision Machinery
300984
5
Wintao Communications
301139
US Stock MarketDetailed Quotes
CSBR Champions Oncology
- 10.330
- -0.060-0.58%
Close Mar 4 16:00 ET
142.75MMarket Cap-206.60P/E (TTM)
10.530High9.936Low29.84KVolume10.290Open10.390Pre Close304.54KTurnover0.57%Turnover RatioLossP/E (Static)13.82MShares11.99052wk High210.82P/B53.95MFloat Cap3.60052wk Low--Dividend TTM5.22MShs Float25.800Historical High--Div YieldTTM5.72%Amplitude0.072Historical Low10.204Avg Price1Lot Size
Champions Oncology Key Stats
Quarterly+Annual
YOY
| (Q2)Oct 31, 2024 | (Q1)Jul 31, 2024 | (FY)Apr 30, 2024 | (Q4)Apr 30, 2024 | (Q3)Jan 31, 2024 | (Q2)Oct 31, 2023 | (Q1)Jul 31, 2023 | (FY)Apr 30, 2023 | (Q4)Apr 30, 2023 | (Q3)Jan 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 16.56%13.49M | 11.94%14.06M | -6.90%50.16M | 7.12%14M | -5.90%12.02M | -18.96%11.57M | -8.61%12.56M | 9.69%53.87M | 1.51%13.07M | -3.18%12.77M |
| Operating revenue | 14.91%12.5M | 10.04%13.07M | -6.90%50.16M | 5.32%16.22M | -7.76%11.18M | -19.73%10.88M | -7.19%11.88M | 14.91%53.87M | 24.54%15.4M | -4.13%12.13M |
| Cost of revenue | 12.24%7.43M | -7.96%7.07M | -0.44%29.4M | -1.20%7.25M | 1.95%7.85M | -11.08%6.62M | 8.96%7.68M | 24.97%29.53M | 17.96%7.34M | 20.18%7.7M |
| Gross profit | 22.32%6.06M | 43.31%6.99M | -14.73%20.75M | 17.77%6.75M | -17.82%4.17M | -27.54%4.96M | -27.13%4.88M | -4.47%24.34M | -13.87%5.73M | -25.24%5.07M |
| Operating expense | -22.88%5.33M | -23.81%5.66M | -3.86%27.68M | -11.53%6.59M | -10.42%6.75M | 1.16%6.91M | 6.48%7.43M | 15.75%28.79M | 6.89%7.45M | 26.44%7.53M |
| Selling and administrative expenses | -17.18%3.64M | -9.28%4.21M | 5.16%18.13M | -1.24%4.54M | 5.33%4.56M | 3.97%4.4M | 13.35%4.64M | 11.27%17.24M | 5.00%4.6M | 14.67%4.33M |
| -Selling and marketing expense | -2.45%1.75M | -1.00%1.68M | 0.89%7.06M | -3.95%1.78M | 2.04%1.8M | 5.59%1.8M | 0.24%1.7M | 9.77%7M | 14.49%1.85M | 13.69%1.76M |
| -General and administrative expense | -27.35%1.89M | -14.05%2.53M | 8.08%11.07M | 0.58%2.76M | 7.59%2.76M | 2.89%2.6M | 22.60%2.94M | 12.32%10.24M | -0.54%2.75M | 15.36%2.57M |
| Research and development costs | -32.84%1.69M | -47.94%1.45M | -17.33%9.54M | -28.12%2.05M | -31.73%2.19M | -3.42%2.52M | -3.26%2.79M | 23.16%11.55M | 10.07%2.85M | 46.81%3.2M |
| Operating profit | 137.44%732K | 152.08%1.33M | -55.56%-6.92M | 109.57%164K | -4.84%-2.58M | -28,028.57%-1.96M | -798.59%-2.55M | -832.95%-4.45M | -451.13%-1.71M | -396.14%-2.46M |
| Net non-operating interest income expense | ||||||||||
| Other net income (expense) | 106.67%7K | -64.29%5K | 52.69%-387K | 57.19%-354K | 61.11%58K | -1,066.67%-105K | 177.78%14K | -3,308.33%-818K | -2,262.86%-827K | 212.50%36K |
| Special income (charges) | ---- | ---- | 46.10%-435K | ---- | ---- | ---- | ---- | ---807K | ---- | ---- |
| -Write off | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --807K | ---- | ---- |
| -Gain on sale of property,plant,equipment | ---- | ---- | ---435K | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
| Other non- operating income (expenses) | 106.67%7K | -64.29%5K | 536.36%48K | 505.00%81K | 61.11%58K | -1,066.67%-105K | 177.78%14K | 54.17%-11K | 42.86%-20K | 212.50%36K |
| Income before tax | 135.87%739K | 152.56%1.33M | -38.75%-7.31M | 92.52%-190K | -4.00%-2.52M | -102,900.00%-2.06M | -740.40%-2.54M | -1,003.43%-5.27M | -634.39%-2.54M | -403.51%-2.42M |
| Income tax | 0.00%11K | -25.00%21K | -147.06%-32K | -505.00%-81K | -35.29%11K | -21.43%11K | 64.71%28K | 94.29%68K | 1,100.00%20K | 54.55%17K |
| Net income | 135.15%728K | 151.17%1.31M | -36.38%-7.28M | 95.74%-109K | -3.73%-2.53M | -12,843.75%-2.07M | -704.39%-2.57M | -1,073.54%-5.34M | -644.48%-2.56M | -409.91%-2.44M |
| Net income continuous Operations | 135.15%728K | 151.17%1.31M | -36.38%-7.28M | 95.74%-109K | -3.73%-2.53M | -12,843.75%-2.07M | -704.39%-2.57M | -1,073.54%-5.34M | -644.48%-2.56M | -409.91%-2.44M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | 135.15%728K | 151.17%1.31M | -36.38%-7.28M | 95.74%-109K | -3.73%-2.53M | -12,843.75%-2.07M | -704.39%-2.57M | -1,073.54%-5.34M | -644.48%-2.56M | -409.91%-2.44M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 135.15%728K | 151.17%1.31M | -36.38%-7.28M | 95.74%-109K | -3.73%-2.53M | -12,843.75%-2.07M | -704.39%-2.57M | -1,073.54%-5.34M | -644.48%-2.56M | -409.91%-2.44M |
| Basic earnings per share | 133.33%0.05 | 152.63%0.1 | -38.46%-0.54 | 94.74%-0.01 | -5.56%-0.19 | -12,579.63%-0.15 | -850.00%-0.19 | -1,075.00%-0.39 | -533.33%-0.19 | -400.00%-0.18 |
| Diluted earnings per share | 133.33%0.05 | 147.37%0.09 | -38.46%-0.54 | 94.74%-0.01 | -5.56%-0.19 | -12,579.63%-0.15 | -850.00%-0.19 | -1,075.00%-0.39 | -533.33%-0.19 | -460.00%-0.18 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion | -- | -- |
Trending Stocks
Discussing
FOMC leaves rates unchanged, how will you adjust your portfolio?
FOMC left the target Federal Funds rate unchanged at at target of 4.25%-4.5%, how will you adjust your portfolio?
Moo Live
Jan 30 03:25
FOMC Press Conference, January 29, 2025